Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

Gabriel Gastaminza, Julián Azofra, Jorge M. Núñez‐Córdoba, M. L. Baeza, S. Echechipía, P Gaig, Blanca E. García, Moisés Labrador‐Horrillo, Marina Sabaté‐Brescó, Ana Beristain,

The Journal of Allergy and Clinical Immunology In Practice · 2019 · 53 citations · 28 references

DOIFull text

Open access

Concepts

References

28